| For: | Xia QL, He XM, Ma Y, Li QY, Du YZ, Wang J. 5-mRNA-based prognostic signature of survival in lung adenocarcinoma. World J Clin Oncol 2023; 14(1): 27-39 [PMID: 36699627 DOI: 10.5306/wjco.v14.i1.27] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v14/i1/27.htm |
| Number | Citing Articles |
| 1 |
Yu Liu, Daosheng Li, Changpeng Xie, Yuanming Pan, Qing Shi. Monoamine Oxidase B in Cancers: Implications for Therapeutics and Prognosis. Journal of Inflammation Research 2025; doi: 10.2147/JIR.S541110
|
| 2 |
Bolin Wang, Xiaofeng Zhou, Di Wu, Lu Gao, Zhihua Wan, Ruifeng Wu. Development and validation of M2 macrophage-related genes in a prognostic model of lung adenocarcinoma based on bulk RNA and ScRNA datasets. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02123-z
|
| 3 |
Yinhua Wang, Fei Liu, Xiuhua Shi, Qinghua Qi, Haibo Ding, Sheng Wang, Zhaoning Ji. Histone H3K18 lactylation promotes malignancy progression in non-small cell lung cancer through TCN1 upregulation. Journal of Molecular Histology 2026; 57(4) doi: 10.1007/s10735-026-10856-6
|
| 4 |
Aneta Prokopcová, Jiří Baloun, Klára Mocová, Ladislav Šenolt. CRTAC1 in extracellular matrix remodeling and calcium signaling: Implications for disease and biomarker development. Life Sciences 2026; 401 doi: 10.1016/j.lfs.2026.124524
|
| 5 |
Haangik Park, Yejin Kim, Hwiin Jo, Myeong-Ha Hwang, Hyojin Son, Sechan Lee, Gwan-Su Yi. Robust prognostic biomarkers and a risk prediction model specific to EGFR-mutated lung adenocarcinoma patients via multicohort meta-analysis. Heliyon 2025; 11(6) doi: 10.1016/j.heliyon.2025.e43007
|